BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/4/2025 12:11:50 PM | Browse: 19 | Download: 41
 |
Received |
|
2025-03-27 03:56 |
|
Peer-Review Started |
|
2025-04-06 08:44 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-15 07:22 |
|
Revised |
|
2025-04-24 09:42 |
|
Second Decision |
|
2025-06-12 02:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-06-13 07:24 |
|
Articles in Press |
|
2025-06-13 07:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2025-06-19 20:58 |
|
Typeset the Manuscript |
|
2025-07-08 00:28 |
|
Publish the Manuscript Online |
|
2025-08-04 12:11 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohamed Mahmoud Hafez, Ibrahim Halil Bahcecioglu, Mehmet Yalniz, Karim Abdelwahab Kouta and Ahmed Tawheed |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ahmed Tawheed, Consultant, Department of Gastroenterology, Firat University, Elazig, Firat Campus, Elazig 23119, Türkiye. atawheed1990@gmail.com |
| Key Words |
Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Biological treatment; Microbiome; Probiotics; Fecal microbiota transplantation; Innovative drug delivery systems; Endoscopy |
| Core Tip |
Inflammatory bowel disease is a chronic gastrointestinal disorder causing persistent inflammation. Traditional treatments include aminosalicylates, corticosteroids, immunomodulators, and biologics. Advanced treatments like small-molecule therapies, targeted biologics, and innovative drug delivery systems have improved bioavailability and reduced side effects. Combining conventional and advanced treatments is crucial for effective treatment. |
| Publish Date |
2025-08-04 12:11 |
| Citation |
<p>Hafez MM, Bahcecioglu IH, Yalniz M, Kouta KA, Tawheed A. Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines. <i>World J Methodol</i> 2025; 15(4): 107643</p> |
| URL |
https://www.wjgnet.com/2222-0682/full/v15/i4/107643.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v15.i4.107643 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
